The target is unspecified (UNKNOWN), and there is no evidence SHR-A1811 binds it. SHR-A1811 is an ADC that kills only antigen-positive cells via binding, internalization, linker cleavage, and intracellular release of a cytotoxic payload (e.g., a topoisomerase I inhibitor), causing DNA damage and apoptosis.